SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : WebMD Health Corp -- Ignore unavailable to you. Want to Upgrade?

To: Raymond Clutts who wrote (111)10/12/2000 2:12:22 PM
From: Bosco  Read Replies (2) | Respond to of 326
 
Hi Raymond - if memory serves, some people did question Clark [& Doerr] timing of the purchase after their announcement of buying an additional $220MM and they said that they didn't do so right away b/c they were insiders. How is that relates to his leaving of the BoD, I ve no idea. If they have a large enough position, don't they still have to file with the SEC? I don't remember the % though.

Ultimately, I see this is a huge transition, with Wygod at the helms, we will have to see his track record with MMGR. And my guess is that Janus will evaluate accordingly too

best, Bosco



To: Raymond Clutts who wrote (111)10/12/2000 4:07:35 PM
From: Sr K  Read Replies (1) | Respond to of 326
 
I did not think he would make a tender. It was a cynical comment that the $220 m is becoming such a large piece of the company that he might fall under the tender offer or GPT regs.

4 for sure.

And, 21 m shares is now under 5%, so Jim Clark has no more disclosure requirements, assuming his shares are registered, IMO.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News